Tops & Flops Stocks
| Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc. | 2.700% | 2.721% | -69.556% | -58.172% | -77.121% | -96.774% | - |
| Bluebird Bio Inc. | -1.300% | -20.296% | -49.990% | -86.025% | -59.358% | -96.728% | -99.461% |
| Forte Biosciences Inc. | 1.350% | 1.351% | -37.500% | -61.039% | -53.488% | -98.760% | - |
| Seres Therapeutics Inc | 0.750% | -8.979% | -36.740% | -78.645% | -44.901% | -87.332% | - |
| Puma Biotechnology Inc. | 0.090% | -4.806% | -35.412% | -34.456% | -42.177% | -64.136% | -76.232% |
| SCYNEXIS Inc. | -5.230% | -6.091% | -32.793% | -60.827% | -32.416% | -75.891% | - |
| Heron Therapeutics Inc. | -7.740% | -1.967% | -29.904% | 19.452% | 11.083% | -82.348% | -89.652% |
| Pacira Pharmaceuticals | - | 7.813% | -26.984% | -58.434% | -53.691% | -71.837% | -58.577% |
| Voyager Therapeutics Inc | -1.520% | -1.331% | -26.290% | -36.915% | -25.409% | 95.323% | -63.597% |
| Editas Medicine Inc | -1.950% | -3.781% | -26.188% | -59.893% | -64.066% | -94.485% | -85.045% |
| Glycomimetics Inc. | -5.900% | -10.693% | -23.924% | -89.674% | -93.274% | -92.042% | -94.875% |
| Ironwood Pharmaceuticals | -1.320% | 1.339% | -23.697% | -45.629% | -55.490% | -58.727% | -45.550% |
| Aspira Womens Health Inc. | -3.470% | 0.581% | -22.768% | -78.642% | -78.642% | -98.128% | -87.445% |
| Fate Therapeutics Inc. | -2.860% | -4.595% | -21.614% | 27.134% | -6.580% | -94.773% | -77.642% |
| Karyopharm Therapeutics Inc. | 4.180% | -7.174% | -20.250% | -45.944% | -17.379% | -86.107% | -91.205% |
| Inotiv Inc. | -12.320% | -8.696% | -18.182% | -61.818% | -61.585% | - | - |
| Acadia Pharmaceuticals | 1.500% | -0.703% | -17.854% | -43.500% | -50.264% | -2.351% | -43.658% |
| ImmunityBio Inc. | -6.960% | -5.069% | -16.503% | 150.140% | -24.216% | -63.305% | 225.478% |
| Neurocrine Bioscience | -4.210% | -13.888% | -16.251% | 14.411% | -1.509% | 45.601% | 28.051% |
| Fibrogen Inc. | -12.510% | -0.511% | -15.370% | -59.279% | -58.556% | -96.626% | -99.135% |
| Omeros Corp. | -0.160% | 2.738% | -15.190% | 15.874% | 19.719% | -71.651% | -77.603% |
| Cytomx Therapeutics Inc | -1.690% | 0.377% | -14.515% | -23.748% | -23.639% | -75.784% | -86.093% |
| Champions Oncology Inc | - | -8.780% | -14.220% | -38.689% | -22.407% | -56.763% | - |
| Sage Therapeutics Inc. | -6.040% | 1.705% | -13.309% | -59.608% | -61.830% | -80.795% | -94.977% |
| Qualigen Therapeutics Inc. | -4.730% | -6.522% | -13.131% | -82.027% | -65.669% | -98.707% | - |